查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1850452

動物腸道健康市場按產品類型、動物類型、應用、配方和分銷管道分類－2025-2032年全球預測

Animal Intestinal Health Market by Product Type, Animal Type, Application, Formulation, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物腸道健康市場規模將成長 67.8 億美元，複合年成長率為 5.95%。

關鍵市場統計數據
基準年 2024 42.6億美元
預計年份：2025年 45.2億美元
預測年份 2032 67.8億美元
複合年成長率 (%) 5.95%

以微生物組科學為指導的策略實施，將腸道健康置於整個畜牧生產系統商業性和永續性的核心地位。

動物腸道健康已從一種小眾營養補充品發展成為畜牧業、水產養殖業和伴侶動物生產系統的核心支柱。微生物組科學的進步使人們重新認知到，腸道健康是一個多因素共同作用的結果，受飼料配方、標靶生物活性、宿主免疫力和管理措施等因素的影響。因此，生產者和價值鏈上的相關人員越來越重視最佳化腸道功能的干涉措施，並將其置於提高動物適應能力、資源利用效率和動物福利策略的核心位置。

同時，監管機構正逐步減少對關鍵抗生素的使用，轉而採用基於實證醫學的替代療法，這推動了對精準飼料添加劑和標靶營養策略的需求。這項轉變伴隨著產品傳輸、診斷監測和數據主導決策等方面的技術整合。綜上所述，這些新興機會意味著腸道健康不再只是一項獨立的技術考量，而是影響動物種類和生產系統盈利、永續性和市場差異化的策略槓桿。

科學突破、監管壓力和數位化物流的融合如何加速動物腸道健康領域整體產品的創新和應用

過去五年，腸道健康領域發生了翻天覆地的變化，產品系列、供應鏈和消費者預期都發生了重塑。科學進步拓寬了有效干預措施的範圍，使其從單一模式的解決方案發展到結合酶、有機酸、植物萃取物、益生元和益生菌以及性能診斷的綜合療法。這種整合得益於菌株鑑定技術的改進、提高穩定性的包埋技術以及針對不同物種和生命階段特定生理需求而客製化的顆粒劑配方。

此外，監管和市場壓力正促使人們以實證替代方案取代頻譜抗菌生長促進劑，從而刺激對臨床試驗、生物標記開發和農場檢驗研究的投資。除了產品創新之外，數位化和物流創新也實現了更精準的給藥、可追溯性和快速的供應協調，縮短了從科學發現到商業性應用的時間。總而言之，這些轉變正在創造一個更複雜但也充滿機會的格局，研發、監管和商業團隊之間的跨職能合作已成為競爭的必然要求。

評估2025年關稅措施對動物腸道藥物生態系中原料採購、配方決策與供應鏈韌性的影響

2025年新關稅措施的實施，為依賴跨境原料流動和配方產品的相關人員帶來了實質的貿易和成本複雜性。關稅將影響進口酵素複合物、特殊有機酸和專有益生菌菌株的經濟效益，迫使製造商和經銷商重新評估籌資策略和庫存政策。事實上，採購團隊正在評估供應商多元化、本地製造夥伴關係以及後向整合，以在控制到岸成本的同時，維持供應的連續性。

此外，關稅帶來的價格訊號正在增強對國產原料和在地化配方的需求。因此，一些價值鏈參與者正在盡可能地加快配方簡化，而另一些參與者則在投資原料替代研究和穩定性測試，以檢驗本地可用的替代品。這些措施正在影響下游產品差異化，能夠展現檢驗性能和成本效益的高階解決方案正在獲得競爭優勢。同時，關稅政策帶來的監管審查正在推動採購和合規方面的透明度提高，進一步加重了小型供應商的行政負擔，並給分銷管道的整合帶來了壓力。

以細分市場為重點的洞察，揭示了產品類型、物種生理、應用、配方限制和分銷策略如何決定產品開發路徑。

深入的市場區隔分析揭示了不同產品類型、動物種類、應用、配方和分銷管道的需求促進因素和產品開發重點。按產品類型分類，市場研究涵蓋酵素、有機酸、植物萃取物、益生元和益生菌。酵素進一步細分為植酸酶、蛋白酶和木聚醣酶，而益生菌則進一步細分為細菌益生菌和酵母益生菌。這種細分凸顯了配方科學的重要性，即需要使觸媒活性、pH耐受性和微生物相容性與目標飼料基質相匹配。依動物種類分類，市場研究涵蓋水產養殖、伴侶動物、家禽、反芻動物和豬。水產養殖進一步細分為魚蝦；伴侶動物細分為貓狗；家禽細分為肉雞、蛋雞和火雞；反芻動物細分為肉牛、乳牛、乳牛和山羊；豬細分為種豬、育肥豬以及母豬和仔豬。這些差異突顯了物種和生命週期特異性的腸道生理，決定了不同的給藥策略、載體系統和療效的證據閾值。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 針對特定牲畜腸道菌叢量身訂製的精準益生菌的應用日益增多
  • 飼料核准核准監管的協調統一將推動動物腸道健康解決方案的成長。
  • 為了改善斷奶後仔豬的腸道健康，人們對飼料中添加抗生素替代品的需求日益成長。
  • 利用次世代定序數據支持客製化動物微生物組干預
  • 針對家禽腸道健康管理中發炎路徑的後生元飼料添加劑的出現
  • 將人工智慧應用於制定牲畜腸道健康精準營養策略

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按產品類型分類的動物腸道健康市場

  • 酵素
    • 植酸酶
    • 蛋白酶
    • 木聚醣酶
  • 有機酸
  • 植物來源成分
  • 益生元
  • 益生菌
    • 細菌益生菌
    • 酵母益生菌

9. 依動物類型分類的動物腸道健康市場

  • 水產養殖
    • 魚
    • 蝦
  • 伴侶動物
    • 貓
    • 狗
  • 家禽
    • 肉雞
    • 產蛋母雞
    • 火雞
  • 反芻動物
    • 肉牛
    • 乳牛
    • 綿羊和山羊
  • 豬
    • 育種者
    • 發光定型劑
    • 母豬和小豬

第10章 動物腸道健康市場（依應用領域分類）

  • 飼料添加劑
  • 營養補充品
  • 治療

第11章：按配方分類的動物腸道健康市場

  • 液體
  • 顆粒
  • 粉末

第12章：按分銷管道分類的動物腸道保健市場

  • 離線
    • 直銷
    • 批發商
  • 線上

第13章：按地區分類的動物腸道健康市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按類別分類的動物腸道健康市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國動物腸道保健市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Cargill, Incorporated
    • Archer Daniels Midland Company
    • Koninklijke DSM NV
    • International Flavors & Fragrances Inc.
    • BASF SE
    • Evonik Industries AG
    • Kemin Industries, Inc.
Product Code: MRR-501246438090

The Animal Intestinal Health Market is projected to grow by USD 6.78 billion at a CAGR of 5.95% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.26 billion
Estimated Year [2025] USD 4.52 billion
Forecast Year [2032] USD 6.78 billion
CAGR (%) 5.95%

A strategic introduction that situates intestinal health as a core commercial and sustainability lever across animal production systems guided by microbiome science

The landscape of animal intestinal health has evolved from niche nutritional supplements to a central pillar of livestock, aquaculture, and companion animal production systems. Advances in microbiome science have reframed intestinal health as a multifactorial outcome driven by feed formulation, targeted bioactives, host immunity, and management practices. As a result, producers and value chain stakeholders are increasingly orienting strategy around interventions that optimize gut function to improve resilience, resource efficiency, and animal welfare.

Concurrently, regulatory momentum away from medically important antibiotics and toward evidence-based alternatives has elevated demand for precision feed additives and targeted nutritional strategies. This shift is accompanied by technological integration in product delivery, diagnostic monitoring, and data-driven decision-making. Collectively, these developments mean that intestinal health is no longer an isolated technical consideration but a strategic lever for profitability, sustainability, and market differentiation across species and production systems.

How converging scientific breakthroughs, regulatory pressure, and digital logistics are accelerating integrated product innovation and adoption across animal intestinal health

The past five years have witnessed transformative shifts that are reshaping product portfolios, supply chains, and buyer expectations in the intestinal health arena. Scientific advancements have broadened the palette of efficacious interventions beyond single-mode solutions to integrated regimens that combine enzymes, organic acids, phytogenics, prebiotics, and probiotics with performance diagnostics. This integration has been accelerated by improvements in strain characterization, encapsulation technologies that enhance stability, and granular formulations that match species- and life-stage-specific physiological needs.

In addition, regulatory and market pressures have incentivized the replacement of broad-spectrum antimicrobial growth promotants with evidence-based alternatives, catalyzing investment in clinical trials, biomarker development, and on-farm validation studies. Parallel to product innovation, digital and logistics innovations are enabling more precise dosing, traceability, and rapid-response supply adjustments, thereby reducing the time between scientific discovery and commercial adoption. Taken together, these shifts are creating a more complex but opportunity-rich landscape in which cross-functional collaboration between R&D, regulatory, and commercial teams becomes a competitive necessity.

Assessment of 2025 tariff impacts on ingredient sourcing, formulation decisions, and supply chain resilience within the animal intestinal health ecosystem

The introduction of new tariff measures in 2025 has introduced a tangible layer of trade and cost complexity for stakeholders who depend on cross-border ingredient flows and formulated products. Tariffs affect the economics of imported enzymatic complexes, specialty organic acids, and proprietary probiotic strains, prompting manufacturers and distributors to reassess sourcing strategies and inventory policies. In practice, this means procurement teams are increasingly evaluating supplier diversification, local manufacturing partnerships, and backward integration to maintain supply continuity while managing landed costs.

Moreover, tariff-induced price signals are reinforcing demand for domestically producible inputs and regionally tailored formulations. As a result, some value chain players are accelerating formulation simplification where feasible, while others are investing in ingredient substitution studies and stability testing to validate locally available alternatives. These dynamics have downstream implications for product differentiation, with premium solutions that demonstrate verifiable performance and cost-efficiency gaining competitive advantage. In parallel, the regulatory scrutiny accompanying tariff policy is encouraging transparency in sourcing and compliance, further increasing the administrative burden on smaller suppliers and creating consolidation pressures across the distribution channel.

Segment-focused insights revealing how product type, species physiology, application intent, formulation constraints, and distribution strategy determine development pathways

Insightful segmentation analysis reveals differentiated demand drivers and product development priorities across product type, animal type, application, formulation, and distribution channel segments. Based on Product Type, the market is studied across Enzymes, Organic Acids, Phytogenics, Prebiotics, and Probiotics, with Enzymes further studied across Phytase, Protease, and Xylanase and Probiotics further delineated into Bacterial Probiotics and Yeast Probiotics; this delineation highlights the need for formulation science that aligns catalytic activity, pH tolerance, and microbial compatibility with target feed matrices. Based on Animal Type, the market is studied across Aquaculture, Companion Animals, Poultry, Ruminants, and Swine, with Aquaculture further studied across Fish and Shrimp, Companion Animals across Cat and Dog, Poultry across Broiler, Layer, and Turkey, Ruminants across Beef Cattle, Dairy Cattle, and Sheep And Goat, and Swine across Breeder, Grower Finisher, and Sow And Piglet; these distinctions underscore species- and lifecycle-specific gut physiology that dictates different dosing strategies, carrier systems, and evidence thresholds for efficacy.

Based on Application, the market is studied across Feed Additive, Nutritional Supplement, and Therapeutic, which implies divergent regulatory pathways, claims substantiation demands, and commercial channels for adoption, while Based on Formulation, the market is studied across Liquid, Pellet, and Powder, indicating formulation constraints related to stability, heat tolerance, and on-farm handling. Finally, Based on Distribution Channel, the market is studied across Offline and Online, with Offline further studied across Direct Sales and Distributor, reflecting evolving go-to-market strategies where direct-to-producer models coexist with distributor networks and digital commerce. Collectively, these segmentation lenses reveal that product development, regulatory strategy, and commercial execution must be tightly aligned to species-specific biology, application intent, and preferred delivery format to accelerate adoption and demonstrate measurable outcomes.

Regional dynamics and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine sourcing, regulatory strategy, and commercialization

Regional differentiation is a decisive factor for supply strategies, regulatory compliance, and on-farm adoption, with distinct dynamics in the Americas, Europe, Middle East & Africa, and Asia-Pacific shaping commercial opportunity and risk. In the Americas, demand drivers are shaped by large-scale commercial poultry and swine operations that prioritize feed conversion and antimicrobial stewardship, prompting rapid adoption of enzyme and probiotic-based interventions that integrate with precision feeding platforms. In Europe, Middle East & Africa, regulatory frameworks and consumer expectations emphasize antibiotic reduction and traceability, which fuels demand for rigorously validated, documentation-ready solutions and encourages partnerships between ingredient innovators and local formulators.

In Asia-Pacific, intensive aquaculture and mixed-species production present both scale and complexity, driving demand for tailored enzyme blends, robust acidifiers, and locally relevant probiotic strains, while online distribution and contract manufacturing models enable rapid scaling. Across regions, the interplay between regional raw material availability, divergent regulatory regimes, and distribution infrastructure necessitates adaptive market entry strategies that balance local partnerships, regulatory intelligence, and formulation flexibility. Consequently, companies that develop region-specific evidence packages and operational models are better positioned to capture cross-border growth while mitigating trade and compliance risks.

Competitive company strategies centered on proprietary science, scalable manufacturing, and integrated service models to secure differentiation and margin

Competitive dynamics are increasingly influenced by the ability to combine scientific credibility with scalable manufacturing and regulatory competence. Key companies are investing in strain characterization, patent-protected enzyme technologies, and multi-site stability studies to substantiate product claims across species and formulations. In addition to product innovation, successful firms are differentiating through supply chain investments such as localized production, contract manufacturing partnerships, and enhanced cold-chain logistics for sensitive biologicals. These capabilities reduce time to market and provide a competitive moat against commodity pricing pressures.

Furthermore, strategic partnerships between ingredient innovators, feed formulators, and service providers are becoming more common, enabling bundled offerings that pair actives with dosers, diagnostics, and on-farm training. This ecosystem approach increases switching costs for end users and creates opportunities for value-added services that extend beyond the point of sale. For leadership teams, the takeaway is clear: scaling R&D, ensuring regulatory readiness across target markets, and embedding distribution and technical service within commercial models are essential to sustain growth and defend margin in a rapidly professionalizing market.

Actionable strategic priorities for leaders to convert scientific innovation into resilient supply chains, validated formulations, and regionally tailored commercial models

Industry leaders should prioritize a set of actionable initiatives to convert scientific promise into commercial outcomes. First, align R&D roadmaps with species-specific evidence generation that addresses on-farm endpoints such as feed efficiency, morbidity reduction, and resilience under variable environmental conditions. Second, invest in formulation and delivery technologies that protect biological actives across processing and storage environments, enabling broader distribution and lower product loss. Third, pursue supply chain resilience through dual-sourcing, regional manufacturing, and strategic inventory positioning to mitigate tariff and logistics disruption risks.

In parallel, commercial teams should develop regionally tailored value propositions that reflect local regulatory expectations and buyer purchasing patterns, including digital channels for technical education and sales conversion. Executives should also consider strategic partnerships that combine diagnostic capabilities with product bundles to demonstrate measurable outcomes and create recurring-service revenue. Finally, establish cross-functional commercialization sprints that rapidly translate trial results into label claims, marketing assets, and distributor training, thereby shortening the adoption curve and improving return on innovation investment.

Methodological framework combining primary interviews, literature synthesis, on-farm validation, and scenario-based supply chain stress testing for actionable findings

The research methodology synthesizes primary interviews, secondary literature review, and cross-functional validation workshops to ensure findings are robust, replicable, and relevant to commercial decision-making. Primary inputs include structured interviews with R&D leaders, procurement specialists, and commercial managers across feed manufacturers, ingredient suppliers, and large producers, complemented by on-farm case studies that validate product performance under production conditions. Secondary inputs are drawn from peer-reviewed journals, regulatory publications, and industry conference proceedings to ground analysis in current scientific consensus and policy trends.

Analytical approaches include comparative formulation analysis, supply chain stress testing under alternative tariff and logistics scenarios, and segmentation mapping that links product attributes to species-specific physiological requirements and application intents. Findings were triangulated through expert workshops and sensitivity checks to ensure practical relevance. Wherever possible, methodological transparency was maintained by documenting data sources, interview protocols, and assumptions used in constructing scenario analyses and strategic recommendations.

Concluding synthesis that positions intestinal health as a systems-level strategic priority requiring evidence, resilience, and regionally tailored commercialization

In conclusion, intestinal health is an increasingly strategic domain that intersects science, regulation, supply chain, and commercial execution. The convergence of microbiome research, regulatory shifts away from antibiotics, and the advent of more robust formulation and delivery technologies has expanded the toolkit available to producers and formulators. At the same time, trade dynamics and tariff developments in 2025 have underscored the importance of supply chain agility and regional manufacturing capabilities. To win in this environment, companies must integrate rigorous evidence generation with resilient sourcing strategies and region-specific go-to-market models.

Looking ahead, the organizations that will succeed are those that treat intestinal health as a systems-level challenge rather than a discrete product category. By investing in species-specific efficacy studies, formulation science, and operational resilience, stakeholders can translate technical innovations into commercial advantage while meeting evolving regulatory and consumer expectations. The recommended path forward emphasizes cross-functional collaboration, regional adaptation, and measurable outcome orientation to sustainably capture the value inherent in healthier animals and more efficient production systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of precision probiotics tailored to specific livestock gut microbiomes
  • 5.2. Regulatory harmonization of feed additive approvals driving growth in animal gut health solutions
  • 5.3. Rising demand for antibiotic alternatives in postweaning pig diets to improve intestinal health
  • 5.4. Utilization of next generation sequencing data to inform customized animal microbiome interventions
  • 5.5. Emergence of postbiotic feed supplements targeting inflammatory pathways in poultry gut health management
  • 5.6. Integration of artificial intelligence in developing precision nutrition strategies for livestock intestinal health

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Intestinal Health Market, by Product Type

  • 8.1. Enzymes
    • 8.1.1. Phytase
    • 8.1.2. Protease
    • 8.1.3. Xylanase
  • 8.2. Organic Acids
  • 8.3. Phytogenics
  • 8.4. Prebiotics
  • 8.5. Probiotics
    • 8.5.1. Bacterial Probiotics
    • 8.5.2. Yeast Probiotics

9. Animal Intestinal Health Market, by Animal Type

  • 9.1. Aquaculture
    • 9.1.1. Fish
    • 9.1.2. Shrimp
  • 9.2. Companion Animals
    • 9.2.1. Cat
    • 9.2.2. Dog
  • 9.3. Poultry
    • 9.3.1. Broiler
    • 9.3.2. Layer
    • 9.3.3. Turkey
  • 9.4. Ruminants
    • 9.4.1. Beef Cattle
    • 9.4.2. Dairy Cattle
    • 9.4.3. Sheep And Goat
  • 9.5. Swine
    • 9.5.1. Breeder
    • 9.5.2. Grower Finisher
    • 9.5.3. Sow And Piglet

10. Animal Intestinal Health Market, by Application

  • 10.1. Feed Additive
  • 10.2. Nutritional Supplement
  • 10.3. Therapeutic

11. Animal Intestinal Health Market, by Formulation

  • 11.1. Liquid
  • 11.2. Pellet
  • 11.3. Powder

12. Animal Intestinal Health Market, by Distribution Channel

  • 12.1. Offline
    • 12.1.1. Direct Sales
    • 12.1.2. Distributor
  • 12.2. Online

13. Animal Intestinal Health Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Animal Intestinal Health Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Animal Intestinal Health Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Cargill, Incorporated
    • 16.3.2. Archer Daniels Midland Company
    • 16.3.3. Koninklijke DSM N.V.
    • 16.3.4. International Flavors & Fragrances Inc.
    • 16.3.5. BASF SE
    • 16.3.6. Evonik Industries AG
    • 16.3.7. Kemin Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ANIMAL INTESTINAL HEALTH MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ANIMAL INTESTINAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL INTESTINAL HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROTEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY XYLANASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ORGANIC ACIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BACTERIAL PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY YEAST PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FISH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHRIMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY CAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DOG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BROILER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LAYER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY TURKEY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SHEEP AND GOAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY BREEDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY GROWER FINISHER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SOW AND PIGLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PELLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANIMAL INTESTINAL HEALTH MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY AQUACULTURE, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COMPANION ANIMALS, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY RUMINANTS, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY SWINE, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY FORMULATION, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY OFFLINE, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA ANIMAL INTESTINAL HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA ANIMAL INTESTINAL